Close Menu

Andy Oram has a post at O'Reilly Radar about positive results from the Peer-to-Patent project, which he calls "one of the most audacious experiments in Internet activism in our day." Peer-to-Patent uses a wiki-style approach to determine whether patent claims are indeed new, inviting technology experts to look at patent applications and then post any prior art relevant to them. "First, people are signing up: over 2,000 so far. Second, they're submitting prior art: 202 pieces," Oram writes. "Most important: they're enjoying the work and would volunteer again."

 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The UK and the European Union have come to a sticking point in the negotiation of how the UK might remain involved in the Horizon Europe research program, the Guardian reports.

The New York Times reports that experts pushed during a meeting of an FDA advisory board for the agency to require more safety data from SARS-CoV-2 vaccine trials.

The Washington Post reports Moderna expects that it will have enough data on its candidate SARS-CoV-2 vaccine to submit to regulatory authorities by mid-November.

In Science this week: ANXA11 variants affect calcium homeostasis and stress granule disassembly in ALS, and more.